REG - Carclo plc - Trading Update

CarcloAnnouncement

15/12/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221215:nRSO7628Ja&default-theme=true

RNS Number : 7628J  Carclo plc  15 December 2022

15 December 2022

Carclo plc

("Carclo" or the "Group")

Trading Update

 

On the 7 December 2022 the Group announced that a new customer supply contract
had been cancelled and the likely financial impact on the results for the year
ending 31 March 2022 was being quantified.

Constructive discussions are ongoing with the customer regarding an
appropriate commercial settlement.  Nevertheless, the Board now anticipates
that profit for the second half of this financial year will be materially
lower than previous expectations.

The Group's lending bank remains supportive and is actively engaged with the
Group to discuss what amendments may be required to address the impact on its
banking covenants.

 

About Carclo plc

 

Carclo plc is a public company whose shares are quoted on the Main Market of
the London Stock Exchange. The Group is a global provider of value-adding
engineered solutions for the medical, optical and aerospace industries.

 

LEI: 21380078MEM399JPI956

 

This announcement contains inside information for the purposes of Article 7 of
Regulation (EU) No 596/2014 as it forms part of UK domestic law by virtue of
the European Union (Withdrawal) Act 2018 ("MAR").

 

 

Enquiries:

 

Carclo plc

01924 268040

 

Frank Doorenbosch - Chief Executive Officer

David Bedford - Chief Financial Officer

 

FTI Consulting

020 3727 1340

Nick Hasell / Susanne Yule

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTFFFFIFILSLIF